Evidence map›Paper›PMID 22607732›Full record

ArticleBMC systems biology2012

Modeling of human factor Va inactivation by activated protein C.

Maria Cristina Bravo, Thomas Orfeo, Kenneth G Mann, Stephen J Everse

Open access · diamondAbstract read
In one paragraph

Article in BMC systems biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Modeling thrombin generation: plasma composition based approach.Journal of thrombosis and thrombolysis · 2014
    Review
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maria Cristina BravoCell and Molecular Biology Program, University of Vermont, 89 Beaumont Ave, Burlington, VT 05405, USA.
Thomas Orfeo
Kenneth G Mann
Stephen J Everse
University of Vermont · US

Funding

VENOUS THROMBOEMBOLISM: GENES, RISK, MANAGEMENTP01HL046703 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BRUMMEL-ZIEDINS, KATHLEEN E · 1991 to 2011
$19.8M
PRIMARY STRUCTURE OF PROTHROMBINR01HL034575 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MANN, KENNETH G · 1985 to 2008
$4.2M
The Prothrombinase Complex: A Model of an Enzyme-Cofactor ComplexF31GM081904 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BRAVO, MARIA CRISTINA · 2007 to 2010
$137k
NHLBI NIH HHS P01 HL 46703NHLBI NIH HHS R01 HL 034575NIGMS NIH HHS F31 GM 81904
6 · The paper itself

Abstract

backgroundBecause understanding of the inventory, connectivity and dynamics of the components characterizing the process of coagulation is relatively mature, it has become an attractive target for physiochemical modeling. Such models can potentially improve the design of therapeutics. The prothrombinase complex (composed of the protease factor (F)Xa and its cofactor FVa) plays a central role in this network as the main producer of thrombin, which catalyses both the activation of platelets and the conversion of fibrinogen to fibrin, the main substances of a clot. A key negative feedback loop that prevents clot propagation beyond the site of injury is the thrombin-dependent generation of activated protein C (APC), an enzyme that inactivates FVa, thus neutralizing the prothrombinase complex. APC inactivation of FVa is complex, involving the production of partially active intermediates and "protection" of FVa from APC by both FXa and prothrombin. An empirically validated mathematical model of this process would be useful in advancing the predictive capacity of comprehensive models of coagulation.

resultsA model of human APC inactivation of prothrombinase was constructed in a stepwise fashion by analyzing time courses of FVa inactivation in empirical reaction systems with increasing number of interacting components and generating corresponding model constructs of each reaction system. Reaction mechanisms, rate constants and equilibrium constants informing these model constructs were initially derived from various research groups reporting on APC inactivation of FVa in isolation, or in the presence of FXa or prothrombin. Model predictions were assessed against empirical data measuring the appearance and disappearance of multiple FVa degradation intermediates as well as prothrombinase activity changes, with plasma proteins derived from multiple preparations. Our work integrates previously published findings and through the cooperative analysis of in vitro experiments and mathematical constructs we are able to produce a final validated model that includes 24 chemical reactions and interactions with 14 unique rate constants which describe the flux in concentrations of 24 species.

conclusionThis study highlights the complexity of the inactivation process and provides a module of equations describing the Protein C pathway that can be integrated into existing comprehensive mathematical models describing tissue factor initiated coagulation.

Indexed as

Models, BiologicalComputer SimulationFactor VFactor VaFactor XaHumansProtein CProthrombinStructure-Activity RelationshipFactor VFactor VaFactor XaProtein CProthrombinprothrombinase complex

Identifiers

PMID22607732
PMCPMC3403913
OpenAlexW2009686070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.